Stock ACIU AC IMMUNE SA
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases AC Immune SA

Equities

ACIU

CH0329023102

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/06/2024 BST 		5-day change 1st Jan Change
3.97 USD -1.00% Intraday chart for AC Immune SA -2.46% -20.60%
05-31 BTIG Starts AC Immune With Buy Rating, $8 Price Target MT
05-13 Sector Update: Health Care Stocks Mixed Late Afternoon MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
AQ
Takeda agrees to develop active immunotherapy for Alzheimer's
AQ
AC Immune: Q1 Earnings Snapshot
AQ
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
AQ
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
AQ
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
AQ
AC Immune Announces Upcoming Presentations at AD/PD™ 2024
AQ
AC Immune to Regain Global Rights to Crenezumab and Semorinemab
AQ
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
AQ
AC Immune : Underwriting Agreement - Form 6-K
PU
AC Immune's Targeted Anti-PTau Active Immunotherapy for Alzheimer's disease Advances into Phase 2b Trial
AQ
AC Immune Announces Pricing of Underwritten Offering of Common Shares
AQ
AC Immune Announces Pricing of Underwritten Offering of Common Shares
AQ
AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
AQ
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
AQ
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
AQ
Women in Stem with Andrea Pfeifer
AQ
AC Immune to Present at the Jefferies 2023 London Healthcare Conference
AQ
AC Immune: Q3 Earnings Snapshot
AQ
AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACIU Stock
  4. News AC Immune SA
  5. Press Releases